PFM Therapeutics Fund, L.P. — Form D/A
PFM Therapeutics Fund, L.P. of SAN FRANCISCO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2017-07-19. $54.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-07-19
- Form: D/A
- Accession: 0001610252-17-000005
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $54.9M
- Investors: 22
- Date of first sale: 2014-07-01
- Security types: fund interests
- SEC file number: 021-219107
Issuer
- Name: PFM Therapeutics Fund, L.P.
- CIK: 0001610252
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: FOUR EMBARCADERO CENTER, SAN FRANCISCO, CA, 94111
- Phone: 415-281-1000
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Christopher James | Executive Officer | New York, NY |
| BRIAN GROSSMAN | Executive Officer | SAN FRANCISCO, CA |
| N/A PARTNER ASSET MANAGEMENT, LLC | Executive Officer | SAN FRANCISCO, CA |
| N/A PARTNER ASSET MANAGEMENT, LLC | Promoter | SAN FRANCISCO, CA |
| William Goodell | Executive Officer | Atlanta, GA |
| Yuan DuBord | Executive Officer | Austin, TX |
| DARIN SADOW | Executive Officer | SAN FRANCISCO, CA |
| N/A PARTNER INVESTMENT MANAGEMENT, L.P. | Promoter | SAN FRANCISCO, CA |
| N/A PARTNER FUND MANAGEMENT, L.P. | Promoter | SAN FRANCISCO, CA |
| Darin M Sadow | Executive Officer | SAN FRANCISCO, CA |
| Christopher M James | Executive Officer | SAN FRANCISCO, CA |
| Yuan M DuBord | Executive Officer | SAN FRANCISCO, CA |
| Eric T Moore | Executive Officer | SAN FRANCISCO, CA |
Other filings by this issuer (7)
More